Teva Pharmaceutical Industries Ltd
TEVA30.330USD
+0.010+0.03%
Cierre 12/19, 16:00（ET）Cotizaciones retrasadas 15 min
34.80BCap. mercado
48.75P/E TTM
Más Datos de Teva Pharmaceutical Industries Ltd Compañía
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Información de Teva Pharmaceutical Industries Ltd
Símbolo de cotizaciónTEVA
Nombre de la empresaTeva Pharmaceutical Industries Ltd
Fecha de salida a bolsaFeb 06, 2087
Director ejecutivoFrancis (Richard D)
Número de empleados33892
Tipo de seguridadDepository Receipt
Fin del año fiscalFeb 06
Dirección124 Dvora Hanevi'a St.
CiudadTEL AVIV-YAFO
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísIsrael
Código postal6944020
Teléfono97239148213
Sitio Webhttps://www.tevapharm.com/
Símbolo de cotizaciónTEVA
Fecha de salida a bolsaFeb 06, 2087
Director ejecutivoFrancis (Richard D)
Ejecutivos de Teva Pharmaceutical Industries Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
13.03K
+9.34%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Mr. Eliyahu Sharon (Eli) Kalif
Mr. Eliyahu Sharon (Eli) Kalif
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Mr. Matthew Shields
Mr. Matthew Shields
Executive Vice President - Teva Global Operations
Executive Vice President - Teva Global Operations
--
--
Mr. Chen Lichtenstein
Mr. Chen Lichtenstein
Independent Director
Independent Director
--
--
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Prof. Varda Shalev
Prof. Varda Shalev
Independent Director
Independent Director
22.50K
+74.83%
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
14.28K
--
Mr. David R. McAvoy
Mr. David R. McAvoy
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
13.03K
+9.34%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
--
--
Mr. Placid Jover
Mr. Placid Jover
Executive Vice President, Chief Human Resources Officer
Executive Vice President, Chief Human Resources Officer
--
--
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
--
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de oct
Divisa: USDActualizado: lun., 6 de oct
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Generic products
2.41B
57.73%
AUSTEDO
498.00M
11.93%
Anda
365.00M
8.74%
Other
247.00M
5.91%
AJOVY
154.00M
3.69%
Otro
501.00M
12.00%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
2.15B
51.51%
Europe
1.30B
31.06%
International Markets
495.00M
11.85%
Other
232.00M
5.56%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Generic products
2.41B
57.73%
AUSTEDO
498.00M
11.93%
Anda
365.00M
8.74%
Other
247.00M
5.91%
AJOVY
154.00M
3.69%
Otro
501.00M
12.00%
Estadísticas de accionistas
Actualizado: dom., 16 de nov
Actualizado: dom., 16 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Phoenix Investment and Finances Ltd
3.60%
Menora Mivtachim Insurance Ltd.
3.39%
Harel Insurance Investments and Financial Services Ltd
3.29%
BlackRock Institutional Trust Company, N.A.
3.04%
Migdal Insurance and Financial Holdings Ltd
2.84%
Otro
83.84%
Accionistas
Accionistas
Proporción
Phoenix Investment and Finances Ltd
3.60%
Menora Mivtachim Insurance Ltd.
3.39%
Harel Insurance Investments and Financial Services Ltd
3.29%
BlackRock Institutional Trust Company, N.A.
3.04%
Migdal Insurance and Financial Holdings Ltd
2.84%
Otro
83.84%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
22.99%
Investment Advisor/Hedge Fund
12.47%
Hedge Fund
10.45%
Insurance Company
6.24%
Research Firm
2.35%
Pension Fund
1.69%
Family Office
1.47%
Bank and Trust
0.90%
Sovereign Wealth Fund
0.24%
Otro
41.19%
Participación institucional
Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
1124
742.23M
64.70%
-84.92M
2025Q2
1100
749.18M
65.31%
-13.97M
2025Q1
1130
727.69M
63.46%
-282.41K
2024Q4
1087
683.52M
59.66%
-22.86M
2024Q3
1029
663.95M
58.60%
-6.13M
2024Q2
1002
631.05M
55.72%
-26.20M
2024Q1
950
595.83M
53.15%
-34.73M
2023Q4
932
601.27M
53.63%
+7.51M
2023Q3
929
573.53M
51.16%
-84.22M
2023Q2
921
512.98M
45.79%
-122.32M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Phoenix Investment and Finances Ltd
37.76M
3.29%
+10.30M
+37.49%
Jun 30, 2025
Menora Mivtachim Insurance Ltd.
57.40M
5%
+18.90M
+49.10%
Jul 16, 2025
Harel Insurance Investments and Financial Services Ltd
33.39M
2.91%
+11.33M
+51.39%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
33.89M
2.95%
+833.03K
+2.52%
Jun 30, 2025
Migdal Insurance and Financial Holdings Ltd
28.69M
2.5%
+2.35M
+8.92%
Jun 30, 2025
Clal Insurance Enterprises Holdings Ltd.
32.36M
2.82%
-5.43M
-14.37%
Jun 30, 2025
Lingotto Investment Management LLP
28.16M
2.45%
+302.98K
+1.09%
Jun 30, 2025
Rubric Capital Management LP
26.00M
2.27%
+450.00K
+1.76%
Jun 30, 2025
PointState Capital LP
20.71M
1.81%
+5.58M
+36.88%
Jun 30, 2025
Fidelity Management & Research Company LLC
50.63M
4.41%
-24.67M
-32.76%
Jun 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares MSCI Israel ETF
7.76%
VanEck Israel ETF
7.5%
VanEck Pharmaceutical ETF
3.79%
First Trust WCM Developing World Equity ETF
3.16%
First Trust WCM International Equity ETF
2.64%
ARK Israel Innovative Technology ETF
1.81%
WealthTrust DBS Long Term Growth ETF
1.42%
WisdomTree International Multifactor Fund
0.77%
iShares Health Innovation Active ETF
0.69%
iShares MSCI Intl Value Factor ETF
0.46%
Ver más
iShares MSCI Israel ETF
Proporción7.76%
VanEck Israel ETF
Proporción7.5%
VanEck Pharmaceutical ETF
Proporción3.79%
First Trust WCM Developing World Equity ETF
Proporción3.16%
First Trust WCM International Equity ETF
Proporción2.64%
ARK Israel Innovative Technology ETF
Proporción1.81%
WealthTrust DBS Long Term Growth ETF
Proporción1.42%
WisdomTree International Multifactor Fund
Proporción0.77%
iShares Health Innovation Active ETF
Proporción0.69%
iShares MSCI Intl Value Factor ETF
Proporción0.46%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Teva Pharmaceutical Industries Ltd?
Los cinco principales accionistas de Teva Pharmaceutical Industries Ltd son:
Phoenix Investment and Finances Ltd posee 37.76M acciones, lo que representa el 3.29% del total de acciones.
Menora Mivtachim Insurance Ltd. posee 57.40M acciones, lo que representa el 5.00% del total de acciones.
Harel Insurance Investments and Financial Services Ltd posee 33.39M acciones, lo que representa el 2.91% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 33.89M acciones, lo que representa el 2.95% del total de acciones.
Migdal Insurance and Financial Holdings Ltd posee 28.69M acciones, lo que representa el 2.50% del total de acciones.
Phoenix Investment and Finances Ltd posee 37.76M acciones, lo que representa el 3.29% del total de acciones.
Menora Mivtachim Insurance Ltd. posee 57.40M acciones, lo que representa el 5.00% del total de acciones.
Harel Insurance Investments and Financial Services Ltd posee 33.39M acciones, lo que representa el 2.91% del total de acciones.
BlackRock Institutional Trust Company, N.A. posee 33.89M acciones, lo que representa el 2.95% del total de acciones.
Migdal Insurance and Financial Holdings Ltd posee 28.69M acciones, lo que representa el 2.50% del total de acciones.
¿Cuáles son los tres principales tipos de accionista de Teva Pharmaceutical Industries Ltd?
Los tres principales tipos de accionista de Teva Pharmaceutical Industries Ltd son:
Phoenix Investment and Finances Ltd
Menora Mivtachim Insurance Ltd.
Harel Insurance Investments and Financial Services Ltd
Phoenix Investment and Finances Ltd
Menora Mivtachim Insurance Ltd.
Harel Insurance Investments and Financial Services Ltd
¿Cuántas instituciones poseen acciones de Teva Pharmaceutical Industries Ltd (TEVA)?
A fecha de 2025Q3, 1124 instituciones poseen acciones de Teva Pharmaceutical Industries Ltd, con un valor de mercado combinado de aproximadamente 742.23M, lo que representa el 64.70% del total de acciones. En comparación con el 2025Q2, el accionariado institucional ha aumentado en -0.61%.
¿Cuál es la mayor fuente de ganancias de Teva Pharmaceutical Industries Ltd?
El FY2025Q2, el segmento empresarial Generic products generó la ganancia más alta para Teva Pharmaceutical Industries Ltd, ascendiendo a 2.41B y representando el 57.73% de la ganancia total.
